1. Home
  2. PACK vs NPCE Comparison

PACK vs NPCE Comparison

Compare PACK & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACK
  • NPCE
  • Stock Information
  • Founded
  • PACK 1972
  • NPCE 1997
  • Country
  • PACK United States
  • NPCE United States
  • Employees
  • PACK N/A
  • NPCE N/A
  • Industry
  • PACK Containers/Packaging
  • NPCE Medical Specialities
  • Sector
  • PACK Consumer Discretionary
  • NPCE Health Care
  • Exchange
  • PACK Nasdaq
  • NPCE Nasdaq
  • Market Cap
  • PACK 313.3M
  • NPCE 292.9M
  • IPO Year
  • PACK N/A
  • NPCE 2021
  • Fundamental
  • Price
  • PACK $5.29
  • NPCE $9.15
  • Analyst Decision
  • PACK Buy
  • NPCE Strong Buy
  • Analyst Count
  • PACK 3
  • NPCE 6
  • Target Price
  • PACK $7.17
  • NPCE $16.67
  • AVG Volume (30 Days)
  • PACK 1.3M
  • NPCE 205.3K
  • Earning Date
  • PACK 08-05-2025
  • NPCE 08-12-2025
  • Dividend Yield
  • PACK N/A
  • NPCE N/A
  • EPS Growth
  • PACK N/A
  • NPCE N/A
  • EPS
  • PACK N/A
  • NPCE N/A
  • Revenue
  • PACK $380,700,000.00
  • NPCE $88,570,000.00
  • Revenue This Year
  • PACK $10.14
  • NPCE $22.13
  • Revenue Next Year
  • PACK $7.92
  • NPCE $6.07
  • P/E Ratio
  • PACK N/A
  • NPCE N/A
  • Revenue Growth
  • PACK 10.38
  • NPCE 23.32
  • 52 Week Low
  • PACK $2.91
  • NPCE $5.45
  • 52 Week High
  • PACK $8.70
  • NPCE $18.98
  • Technical
  • Relative Strength Index (RSI)
  • PACK 67.12
  • NPCE 51.74
  • Support Level
  • PACK $5.02
  • NPCE $8.61
  • Resistance Level
  • PACK $6.31
  • NPCE $8.99
  • Average True Range (ATR)
  • PACK 0.33
  • NPCE 0.53
  • MACD
  • PACK 0.10
  • NPCE 0.11
  • Stochastic Oscillator
  • PACK 55.24
  • NPCE 75.00

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of its revenue from Europe/Asia. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: